Extruded and spheronized beads containing no microcrystalline cellulose: Influence of formulation and process variables

Pharmaceutical Development and Technology

Volumn 9, Issue 2, 2004, Pages 197-217

  Agrawal, Anjali M ^a   Howard, Matthew A ^b   Neau, Steven H ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b IQVIA   (United States)

Author keywords

Chitosan; Ethylcellulose; Extrusion spheronization; Regression equation; Screening design

Indexed keywords

CAFFEINE; CHITOSAN; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; DENSITY; DRUG RELEASE; DRUG STRUCTURE; PELLET EXTRUSION; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPHERONIZATION; STATISTICAL ANALYSIS; TABLET FRIABILITY; WATER CONTENT;

CAFFEINE; CELLULOSE; CHITIN; CHITOSAN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; METHYLCELLULOSE; PARTICLE SIZE; POROSITY; TIME FACTORS;

EID: 2942737072     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120030250     Document Type: Article

References (40)

1. Tuleu, C.; Andrieyx, C.; Boy, P.; Chaumeil, J.C. Gastrointestinal transit of pellets in rats: effect of size and density. Int. J. Pharm. 1999, 180 (1), 123-131.
2. Umprayn, K.; Chitopras, P.; Amarekajorn, S. Influence of process variables on physical properties of the pellets using extruder and spheronizer. Drug Dev. Ind. Pharm. 1999, 25 (1), 45-61.
3. Mehta, K.A.; Serpil, M.; Phuapradit, W.; Malick, A.W.; Shah, H.N. Effect of formulation and process variables on porosity parameters and release rates from a multi-unit erosion matrix of a poorly soluble drug. J. Control. Release 2000, 63 (1-2), 201-211.
4. Fielden, K.E.; Newton, J.M.; O'Brien, P.; Rowe, R.C. Thermal studies on the interaction of water and microcrystalline cellulose. J. Pharm. Pharmacol. 1988, 40 (10), 674-678.
5. Harrison, P.J.; Newton, J.M.; Rowe, R.C. Convergent flow analysis in the extrusion of wet powder masses. J. Pharm. Pharmacol. 1984, 36 (12), 796-798.
6. Bains, D.; Boutell, S.L.; Newton, J.M. The influence of moisture content on the preparation of spherical granules of barium sulfate and microcrystalline cellulose. Int. J. Pharm. 1991, 69, 233-237.
7. Harrison, P.J.; Newton, J.M.; Rowe, R.C. The characterization of wet powder masses suitable for extrusion/spheronization. J. Pharm. Pharmacol. 1985, 37 (10), 686-691.
8. Harrison, P.J.; Newton, J.M.; Rowe, R.C. Flow defects in wet powder mass extrusion. J. Pharm. Pharmacol. 1985, 37 (2), 81-83.
9. Baert, L.; Fanara, D.; Remon, J.P.; Massart, D. Correlation of extrusion forces, raw materials and sphere characteristics. J. Pharm. Pharmacol. 1992, 44 (8), 676-678.
10. Kleinebudde, P. The crystallite-gel model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization. Pharm. Res. 1997, 14 (6), 804-809.
11. Kleinebudde, P.; Schroder, M.; Schultz, P.; Muller, B.W.; Waaler, T.; Nymo, L. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures. Pharm. Dev. Technol. 1999, 4 (3), 397-404.
12. Malinowski, H.J.; Smith, W.E. Use of factorial design to evaluate granulations prepared by spheronization. J. Pharm. Sci. 1975, 64 (10), 1688-1692.
13. Rowe, R.C.; Sadeghnejad, G.R. The rheology of microcrystalline cellulose powder/water mixes-measurement using a mixer torque rheometer. Int. J. Pharm. 1987, 38, 227-229.
14. Basit, A.W.; Newton, J.M.; Lacey, L.F. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm. Dev. Technol. 1999, 4 (4), 499-505.
15. Millili, G.P.; Schwartz, J.B. The strength of MCC pellets: the effect of granulating with water/ethanol mixtures. Drug Dev. Ind. Pharm. 1990, 16, 1411-1426.
16. Elbers, J.A.C.; Bakkenes, H.W.; Fokkens, J.G. Effect of amount and composition of granulation liquid on mixing, extrusion and spheronization. Drug Dev. Ind. Pharm. 1992, 18, 501-517.
17. Lindner, H.; Kleinebudde, P. Use of powdered cellulose for the production of pellets by extrusion/ spheronization. J. Pharm. Pharmacol. 1994., 46 (1), 2-7.
18. Mehta, K.A.; Killalioglu, M.S.; Phuapradit, W.; Malick, A.W.; Shah, H.N. Release performance of poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. Int. J. Pharm. 2001, 213 (1-2), 7-12.
19. Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 1998, 15 (9), 1326-1331.
20. Sawayanagi, Y.; Nambu, N.; Nagai, T. Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch. Chem. Pharm. Bull. 1982, 30 (8), 2935-2940.
21. Genta, I.; Pavanetto, F.; Conti, B.; Giunchedi, P.; Conte, U. Improvement of dexamethasone dissolution rate from spray-dried chitosan microspheres. STP Pharma Sci. 1995, 5, 202-207.
22. Kawashima, Y.; Lin, S.Y.; Kasai, A.; Handa, T.; Takenaka, H. Preparation of a prolonged release tablet of aspirin with chitosan. Chem. Pharm. Bull. 1985, 33 (5), 2107-2113.
23. Chandy, T.; Sharma, C.P. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. Biomaterials 1992, 13 (13), 949-952.
24. Shiraishi, S.; Imai, T.; Otagiri, M. Controlled-release preparation of indomethacin using calcium alginate gel. Biol. Pharm. Bull. 1993, 16 (11), 1164-1168.
25. Aiedeh, K.; Gianasi, E.; Orienti, I.; Zecchi, V. Chitosan microcapsules as controlled release systems for insulin. J. Microencapsul. 1997, 14 (5), 567-576.
26. Ratto, J.; Hatakeyama, T.; Blumstein, R.B. Differential scanning calorimetry investigation of phase transitions in water/chitosan systems. Polymer 1995, 36 (15), 2915-2919.
27. Santos, H.; Veiga, F.; Pina, M.; Podczeck, F.; Sousa, J. Physical properties of chitosan pellets produced by extrusion-spheronization: influence of formulation variables. Int. J. Pharm. 2002, 246, 153-169.
28. Goskonda, S.R.; Upadrashta, S.M. Avicel RC-591/ chitosan beads by extrusion-spheronization technology. Drug Dev. Ind. Pharm. 1993, 19 (8), 915-927.
29. Tapia, C.; Buckton, G.; Newton, J.M. Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/ spheronization. Int. J. Pharm. 1993, 92, 211-218.
30. Podczeck, F.; Rahman, S.R.; Newton, J.M. Evaluation of a standardized procedure to assess the shape of pellets using image analysis. Int. J. Pharm. 1999, 192, 123-138.
31. Parrott, E.L. Milling. In The Theory and Practice of Industrial Pharmacy, 3rd Ed.; Lachman, L., Lieberman, H.A., Kanig, J.L., Eds.; Lee & Febiger: Philadelphia, 1987; 27-28.
32. Martin, A. Micromeritics. In Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences, 4th Ed.; Martin, A., Ed.; Lee & Febiger: Philadelphia, 1993; 444.
33. Kulkarni, S.K. Extruded and spheronized beads containing fine particle ethylcellulose. M.S. Thesis; University of Missouri-Kansas City, 2001.
34. Pollock, D.K.; Sheskey, P.J. Micronized ethylcellulose: opportunities in direct compression controlled-release tablets. Pharm. Technol. 1996, 20, 120-130.
35. Reynolds, A.D. A new technique for the production of spherical particles. Manuf. Chem. Aerosol News 1970, 41, 40-43.
36. Nigalaye, A.G.; Adusumilli, P.; Bolton, S. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev. Ind. Pharm. 1990, 16, 449-467.
37. Erkoboni, D.F. Extrusion-spheronization as a granulation technique. In Handbook of Pharmaceutical Granulation Technology; Parikh, D.M., Ed.; Marcel Dekker: New York, 1997; 333-368.
38. Pinto, J.F.; Buckton, G.; Newton, J.M. The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronization. Int. J. Pharm. 1992, 83, 187-196.
39. Shah, R.; Kabadi, M.; Pope, D.G.; Augsberger, L.L. Physico-mechanical characterization of the extrusion/spheronization process. Part I: instrumentation of the extruder. Pharm. Res. 1994, 11, 355-360.
40. Sousa, J.J.; Sousa, A.; Podczeck, F.; Newton, J.M. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int. J. Pharm. 2002, 232, 91-106.